Stealth: Stealth BioTherapeutics to receive FARA grant to develop investigational mitochondrial therapeutic SBT589 for Friedreich's ataxia

Stealth BioTherapeutics Inc., a clinical─stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction and the